|
TEX2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.08450001704108E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.32519997595193E-09 |
| Normal-vs-Stage2 |
1.673020E-01 |
| Normal-vs-Stage3 |
1.765254609154E-14 |
| Normal-vs-Stage4 |
1.77524661637563E-13 |
| Stage1-vs-Stage2 |
1.715790E-03 |
| Stage1-vs-Stage3 |
1.985750E-02 |
| Stage1-vs-Stage4 |
2.115700E-03 |
| Stage2-vs-Stage3 |
4.1897000000013E-05 |
| Stage2-vs-Stage4 |
4.00639999997843E-06 |
| Stage3-vs-Stage4 |
3.699200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.7728045394233E-11 |
| Normal-vs-AfricanAmerican |
3.951700E-04 |
| Normal-vs-Asian |
8.12440004160919E-10 |
| Caucasian-vs-AfricanAmerican |
3.184200E-01 |
| Caucasian-vs-Asian |
7.472400E-01 |
| AfricanAmerican-vs-Asian |
1.782450E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.46749953802805E-10 |
| Normal-vs-Female |
2.97970004226045E-09 |
| Male-vs-Female |
1.748630E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.97839999938054E-09 |
| Normal-vs-Age(41-60Yrs) |
9.25269999507705E-08 |
| Normal-vs-Age(61-80Yrs) |
1.27059999965873E-07 |
| Normal-vs-Age(81-100Yrs) |
1.632620E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.261400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.136800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.432600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.123600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.126000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.121400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.447600E-04 |
| Classical-VS-Follicular |
1.48089999996159E-06 |
| Classical-VS-Other |
9.015800E-01 |
| Classical-VS-Normal |
7.12474523822948E-12 |
| Tall-VS-Follicular |
2.38009945086048E-10 |
| Tall-VS-Other |
1.375420E-01 |
| Tall-VS-Normal |
3.5527136788005E-15 |
| Follicular-VS-Other |
1.246100E-02 |
| Follicular-VS-Normal |
1.033600E-01 |
| Other-VS-Normal |
1.837550E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.19909999996004E-06 |
| Normal-vs-N1 |
1.55431223447522E-14 |
| N0-vs-N1 |
1.85519999995609E-06 |
|
|
